In connection with the investment agreement, Cinven has announced that it intends to submit a voluntary public purchase offer of EUR 10.00 in cash per SYNLAB share. This puts Synlab AG at a market capitalization of approx. EUR 2.2 billion. Cinven has concluded agreements with shareholders of SYNLAB AG ahead of the deal, securing a total of almost 80% of the voting rights in the target. SYNLAB AG has its registered office in Munich. Its shares are traded on the regulated market (Prime Standard) of Deutsche Börse AG in Frankfurt am Main and listed in the SDAX index. The SYNLAB Group has around 30,000 employees across more than 30 countries and generates annual revenue of more than EUR 3 billion. Cinven is a global private equity firm with more than EUR 39 billion in combined assets under management. Its portfolio companies have collectively generated a total revenue of more than EUR 44 billion.